Skip to content
OpenCapital
Get started

Intellia Therapeutics NTLA Enterprise value

Enterprise value at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$12.92B+175%
ALN
Alnylam PharmaceuticalsALNY
$42.43B+24.1%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$4.93B+69.8%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$2.39B+51.2%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$1.3B+33.2%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$1.86B+85.0%

Other financials

Income statement

See full
Revenue$15.0M-9.5%
Operating income-$100.5M+16.8%
Net income-$96.2M+15.8%
EPS (diluted)-$0.81+26.4%

Balance sheet

See full
Cash & equivalents$134.7M+6.2%
Total debt$80.5M-32.5%
Total equity$620.9M-20.4%
Total assets$758.8M-23.1%

Cash flow

See full
Operating cash flow-$117.3M+21.2%
CapEx$79.0K-89.3%
Free cash flow-$117.4M+21.5%

Valuation

See full
Market cap$2.13B+106%
P/S32.2×+9.5×

Profitability

See full
Operating margin-636.6%-202pp
Net margin-597%-194pp
FCF margin-550.2%-140pp

Returns & leverage

See full
Return on equity-56.3%-1.5pp
Debt / equity0.1×0.0×
Current ratio6.1×+1.2×

Where this comes from

Calculated from Intellia Therapeutics’s reported figures.

$1.5Bmarket cap+$80.5Mtotal debt−$134.7Mcash and equivalents=$1.46B

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Intellia Therapeutics's enterprise value?
Intellia Therapeutics (NTLA) reported enterprise value of $1.46B in Q1 2026.
How has Intellia Therapeutics's enterprise value changed year-over-year?
Intellia Therapeutics's enterprise value increased by 100.5% year-over-year, from $728.38M to $1.46B.
What is the long-term trend for Intellia Therapeutics's enterprise value?
Over 5 years (2020 to 2025), Intellia Therapeutics's enterprise value has grown at a -24.3% compound annual growth rate (CAGR), from $3.93B to $979.18M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.